>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
环孢菌素A联合经典化疗方案治疗难治性急性白血病临床观察
作者:李静 殷献录 
单位:蚌埠市第三人民医院,血液科,安徽,蚌埠,233000
关键词:急性白血病 难治性 多药耐药 环孢菌素 化学治疗 
分类号:R733.71, R730.53
出版年·卷·期(页码):2007·26·第六期(449-451)
摘要:

目的:探讨环孢菌素A(CsA)作为耐药逆转剂联合化疗逆转难治性急性白血病(RAL)多药耐药(MDR)的临床疗效.方法:56例RAL患者随机分为逆转剂组30例(予CsA加经典化疗)和对照组26例(予经典化疗).所有患者治疗前行耐药糖蛋白P-糖蛋白(P-gp)检测,比较两组MDR的逆转情况.结果:P-gp在RAL中高表达(62.5%).逆转剂组治疗完全缓解(CR)率43.33%,总有效率66.67%;其中P-gp高表达者CR率52.63%,总有效率68.42%.对照组CR率19.23%,总有效率38.46%.逆转剂组总有效率明显高于对照组,差异有显著性(P<0.05).结论:CsA能够逆转RAL的耐药性,CsA联合经典化疗方案治疗RAL特别是P-gp高表达者有良好的应用价值.

Objective To investigate the clinical effect of cyclosporin A(CsA) as a reversal agent associated with classical chemotheraphy to reverse multidrug resistance(MDR) in refractory acute leukemia(RAL).Methods 56 cases of RAL were divided into reversal group(CsA combined chemotherapy) and control group(classic chemotherapy) at random.Before treatment drug resistance glucoprotein(P-gp) were detected in all patients.Reversal of multidrug resistance was compared between reversal group and control group.Results P-gp was overexpressed in RAL(62.5%).The rate of complete remission was 43.33% in reversal group and the overall effective rate was 66.67%;The rate of complete remission was 52.63% and the total effective rate was 68.42% in the group overexpressed with P-gp.The rate of complete remission was 19.23% and the total effective rate was 38.46% in control group.The curative effect in revesal group was higher than that in control group and the difference was significant(P<0.05).Conclusion CsA can reverse the drug resistance of RAL.CsA associated with classic chemoscheme is valuabe to cure RAL especially in the group with overexpression of P-gp.

参考文献:

[1] 沈志详, 欧阳仁荣. 血液肿瘤学, 1999
[2] 张之南, 沈悌. 血液病诊断与疗效标准, 1998
[3]. 关于难治性急性白血病诊断及疗效标准的建议(草案), 2000(1)
[4] HE L, LIU G O. Interaction of multidrug resistance reversal agents with P-glycoprotein ATP-ase activity on blood-brain barrier, 2002(5)
[5] 柴晔, 张连生, 张玉芳. 环孢菌素A与干扰素联合逆转复发难治性急性白血病多药耐药的临床研究. 临床血液学杂志2003(5). doi:10.3969/j.issn.1004-2806.2003.05.005
[6] 赵春亭, 杨纯正, 杨天溢. CsA逆转白血病的多药耐药机制的实验研究. 白血病·淋巴瘤2001(2). doi:10.3760/cma.j.issn.1009-9921.2001.02.002

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 414036 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364